Walgreens Boots Alliance (NASDAQ:WBA) PT Raised to $10.00 at UBS Group

Walgreens Boots Alliance (NASDAQ:WBA) had its target price lifted by equities researchers at UBS Group from $9.00 to $10.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the pharmacy operator’s stock. UBS Group’s target price indicates a potential downside of 7.32% from the company’s previous close.

WBA has been the topic of a number of other research reports. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. reduced their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday. Royal Bank of Canada reduced their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a report on Tuesday, July 2nd. Finally, Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $13.38.

Walgreens Boots Alliance Stock Up 1.2 %

Shares of Walgreens Boots Alliance stock opened at $10.79 on Thursday. The company has a market cap of $9.31 billion, a price-to-earnings ratio of -1.60, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The company’s 50 day moving average is $9.41 and its 200 day moving average is $13.14. Walgreens Boots Alliance has a twelve month low of $8.22 and a twelve month high of $27.05. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.67 earnings per share. Research analysts anticipate that Walgreens Boots Alliance will post 2.85 EPS for the current year.

Institutional Trading of Walgreens Boots Alliance

Hedge funds and other institutional investors have recently modified their holdings of the company. Scientech Research LLC purchased a new stake in shares of Walgreens Boots Alliance in the second quarter worth $1,215,000. Ariel Investments LLC increased its holdings in Walgreens Boots Alliance by 10.8% in the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock valued at $24,660,000 after acquiring an additional 198,891 shares during the last quarter. Exchange Traded Concepts LLC bought a new stake in Walgreens Boots Alliance in the 3rd quarter valued at $795,000. Clifford Capital Partners LLC increased its holdings in Walgreens Boots Alliance by 58.4% in the 2nd quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator’s stock valued at $9,715,000 after acquiring an additional 296,135 shares during the last quarter. Finally, EP Wealth Advisors LLC bought a new stake in Walgreens Boots Alliance in the 4th quarter valued at $297,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.